Evidence map
What has to stay separate
The account treats "fractal" as a measurable stimulus property rather than a
vague synonym for complexity. The narrow problem is the Russian fractal phototherapy and
stereoscopic-display line, plus the retinal, lighting, entrainment,
and comparator literatures needed to understand what those claims
might amount to.
The core fractal-phototherapy literature is niche, so it needs
independent comparison and replication context rather than the
confidence of a settled intervention base. Nearby comparator material
includes disease-specific reports on dry age-related macular
degeneration and Stargardt disease, but those reports remain evidence
to read carefully rather than a public treatment claim.
As of May 20, 2026, the public record has a clearer shape: a broad
brain-training patent, a narrower stereoscopic-display patent, 2024 methods and
VR-rehabilitation papers, a 2025 software / clinical-trials report, and small
disease-specific papers on dry AMD and Stargardt disease. That is enough for a
careful map, with public efficacy still unproven.
The evidence has to stay bounded. Spatial and temporal structure,
ophthalmic and broader neurodynamic claims, and direct evidence and
adjacent context such as biophilic fractal design, ipRGC lighting, or
gamma entrainment all need to remain distinguishable.
Current evidence map
- Core fractal-phototherapy papers, patents, and clinical claims
- Patent lineage from broad sensory-stimulation platform to ophthalmic stereoscopic-display method
- Disease-specific visual-rehabilitation reports on dry AMD and Stargardt disease
- Retinal and ophthalmic context for disease relevance and mechanism
- Comparator stimulation families: 40 Hz, 60 Hz, heterochromatic flicker, and lighting-design work
- Methods notes on fractal image analysis and temporal-stimulus generation
Synthesis
Fractal structure as stimulus, not vibe
Fractal language is useful only when it stays tied to modality,
measurement, and outcome.
Fractal means structure
Fractal Optics starts from a simple constraint: "fractal" should stay tied to
structure rather than float as a synonym for organic, beautiful, recursive,
healing, or complex. A fractal claim
needs a structure that can be described, generated, measured, or compared. If a
stimulus has spatial self-similarity, temporal modulation, lacunarity, box
dimension, spectral slope, or a defined generation rule, then there is
something to discuss. If it is merely an aesthetic resemblance, the claim stays
aesthetic.
The distinction matters because the subject sits near clinical and
rehabilitation language. Retinal stimulation, fractal phototherapy, VR delivery, flicker,
entrainment, lighting, and photobiomodulation can sound related in public
summaries. Each belongs to a different evidence path. A spatial fractal image, a temporal
flicker sequence, a wavelength-specific light treatment, and an immersive game
scene may all use light, but they reach the visual system through different
channels and carry different evidence burdens.
The evidence line and the comparator line
A workable reading keeps two lines separate. One line follows the Russian fractal
phototherapy and ophthalmic rehabilitation literature as a specific
intervention family, with attention to diagnosis, delivery mode, outcome
measure, and source quality. The other line tracks comparators: flicker at
different frequency bands, heterochromatic stimulation, melanopsin and ipRGC
lighting pathways, photobiomodulation, spatial-fractal preference, restorative
visual environments, and broader entrainment claims.
Comparators help define where the fractal line begins and ends. They can suggest
mechanisms worth checking, but they cannot substitute for direct evidence. A
40 Hz entrainment study, a blue-light circadian result, a photobiomodulation
paper, and a fractal-fluency finding cannot automatically combine into one
therapy. Fractal Optics has to resist that kind of easy synthesis.
What the current sources say
The public sources now have a defined spine. RU2671199C1 belongs to the broad
sensory-stimulation and brain-training layer. RU2773684C1 is the narrower
ophthalmic patent layer, built around fractal phototherapy with a stereoscopic
head-mounted display. The 2024 methods paper describes portable and VR routes.
The 2025 stereoscopic-display paper and the disease-specific reports add
implementation and clinical-study records.
The dry AMD report matters because it puts the method into a named retinal
disease group and reports ERG changes after a two-week VR course. The Stargardt
report matters because it extends the same line into a very small STGD1 sample
and explicitly leaves larger confirmation work open. Those sources make the map
more concrete, but they also make the caution sharper.
What VR delivery would have to show
VR makes the question more interesting and more difficult. A headset can
control field of view, stereo depth, attention, timing, interaction, and
compliance in ways a flat display cannot. It can also introduce confounds:
optics, accommodation-vergence mismatch, motion discomfort, novelty, game
framing, and adherence effects. In the current public source line, VR is best
read first as a delivery, field-control, attention, and adherence surface. If it
is also meant to be a therapeutic variable, the delivery method has to be part
of the claim rather than a decorative carrier.
A strong VR claim would specify what is fractal, what is temporal, what is
spatial, what part of the retina or visual pathway is being targeted, what the
user is doing, what the comparison condition is, and what outcome changed. A
weak claim would only say that immersive fractals are therapeutic. The
first route should stay open; the second should stay out.
Why the evidence stays cautious
Fractal Optics still lacks enough evidence for a treatment claim. The useful work is
separation: each source has to be read by modality, structure, carrier,
frequency, outcome, and evidence type. That sounds modest, but it is the
difference between a usable research map and a persuasive collage.
The cautious stance also keeps the line compatible with design work.
Fractal stimuli may still be useful for attention, comfort, perceptual fluency,
fascination, or experimental probing even where therapeutic claims remain
unproven. The point is to say which claim is being made each time.